Erectile Dysfunction Market Size, Share, Growth Analysis, By Product(Viagra, Cialis, Zydena, Levitra), By Region - Industry Forecast 2024-2031


Report ID: SQSG35I2033 | Region: Global | Published Date: July, 2036
Pages: 165 |Tables: 39 |Figures: 73

Erectile Dysfunction Market Insights

Erectile Dysfunction Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.49 billion in 2023 to USD 4.73 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

The inability to achieve or sustain a robust adequate penile erection during sexual activity is known as erectile dysfunction. It is the most prevalent condition affecting male sexual health. Because of stress, has an impact on the patient's physical and mental health. There are two basic causes of erectile dysfunction: psychological and physiological. Physiological causes include high blood pressure, high cholesterol, obesity, diabetes, smoking, and tobacco use.

The market for erectile dysfunction treatments is expanding as a result of an increase in the number of individuals with erectile dysfunction. Throughout the projection period, market participants are anticipated to become more knowledgeable about erectile dysfunction treatment. Nevertheless, one of the primary issues projected to limit the growth of the erectile dysfunction market is the high cost of penile implants.

US Erectile Dysfunction Market  is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 2.3 billion

Largest Segment

Cialis

Fastest Growth

Cialis

Growth Rate

8.5% CAGR

Global Erectile Dysfunction Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Erectile Dysfunction Market Segmental Analysis

The global erectile dysfunction market segmentation is based on product, and region. Based on product the Erectile Dysfunction Market is segmented into viagra, cialis, zydena, levitra, stendra, and others. Based on region the global erectile dysfunction market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Erectile Dysfunction Market Analysis by Product

In 2021, the category selling viagra had the biggest revenue share at 57.8%. Many businesses are currently engaging in a variety of strategic activities to grow their market share, including research alliances, agreements, and partnerships.

Due to the wide application base and accessibility of ED medications like Helleva (lodenafil carbonate), Mvix (mirodenafil), and others that are also used to treat adult patients with erectile dysfunction, the other segment is also anticipated to experience profitable market growth over the forecast period. Increased acceptance of over-the-counter ED medications gives patients easy access. Therefore, the release of such goods could increase the use of ED medications.

Global Erectile Dysfunction Market Share By Grade Product (%)

To get detailed analysis on other segments, Request For Free Sample Report

Erectile Dysfunction Market Regional Insights

The erectile dysfunction industry is expected to be dominated by North America. The prevalence of erectile dysfunction, the well-developed healthcare system, and the accessibility of treatment tools are all factors in the supremacy.

Due to regulatory agencies' evaluation of erectile dysfunction medicines, the market for erectile dysfunction treatments is also anticipated to rise significantly in Europe. The market expansion in this region is projected to be fueled by the rising elderly population as well as many product launches by major market competitors.

The highest CAGR is anticipated to be recorded in the Asia Pacific. Growing patient populations with erectile dysfunction are projected to fuel this region's market expansion as the demand for medications like sildenafil and tadalafil rises.

The markets in the Middle East and Africa, as well as Latin America, are still developing. However, rising patient awareness of the condition and the medication in these areas is probably going to contribute to a sizable increase in the market in the coming years.

Global Erectile Dysfunction Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Erectile Dysfunction Market Dynamics

Erectile Dysfunction Market Driver

  • Diabetes, obesity, and cardiovascular disease are on the rise due to the rise in the adoption of an unhealthy lifestyle, which in turn causes issues like ED as people age. Young people's current lifestyles are particularly stressful in many emerging nations, which has led to an increase in fast food and ready-to-eat food consumption as well as drinking and smoking. These variables are compromising general health and fitness, which in turn raises the risk of ED. Additionally, the number of ED patients increases along with the senior population growth, which continues to be a major driver of the worldwide erectile dysfunction medications market during the projection period.
  • Major and growing pharmaceutical brands have boosted their investments in developing nations like India, China, Africa, and important Middle Eastern nations during the past couple of years. This has had a huge impact on the cost of medicine as well as the availability and distribution of medicines within the nations, both of which are anticipated to be important. The global market for erectile dysfunction medications is also anticipated to grow dramatically as a result of increased advertising investments.
  • Increasing research and development activities by the market players to provide new treatments for erectile dysfunction is expected to drive the growth of the market.

Erectile Dysfunction Market Restraint

  • Drugs for erectile dysfunction are primarily sold in developed and emerging economies; but, low- and middle-income countries account for a smaller portion of their sales. This is primarily a result of people's lack of understanding of these types of treatments, their limited purchasing power, and their unwillingness to incorporate them into their daily lives. The slow growth of the market is partly attributed to the negative side effects of these medications, which include headache, upset stomach, flushing, nasal congestion, visual issues, dizziness, diarrhea, and rash.
  • Two significant market challenges are the increased production of generic erectile dysfunction medications and the rising accessibility of fake erectile dysfunction medications. Due to the lucrative marketing of counterfeit erectile dysfunction medications at noticeably lower prices than either patented or generic pharmaceuticals, consumers frequently opt for less expensive generic erectile dysfunction pills over more expensive blockbuster varieties.

Request Free Customization of this report to help us to meet your business objectives.

Erectile Dysfunction Market Competitive Landscape

Key market participants in the erectile dysfunction (ED) drugs market are strengthening their market positions by implementing a variety of strategies, including mergers and acquisitions and research partnerships with other businesses, to introduce novel products and solidify their market positions globally. For instance, due to a production error, Sun Pharmaceutical Industries Ltd. announced the recall of their generic medicine Tadalafil in November 2021. A small gap in the availability of generic ED medications used to treat erectile dysfunction patients may result from this recall.

Erectile Dysfunction Market Top Players Company Profiles

  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • VIVUS, Inc.
  • Dong-A ST Co. Ltd.
  • Meda Pharmaceuticals Inc.
  • S.K. Chemicals Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Endo International plc
  • Futura Medical plc
  • Apricus Biosciences, Inc.
  • Medtronic plc
  • Coloplast Corp.
  • Boston Scientific Corporation
  • Zephyr Surgical Implants
  • Urologix, LLC
  • American Medical Systems, Inc.
  • Augusta Medical Systems, LLC
  • Pos-T-Vac Medical

Erectile Dysfunction Market Recent Development

  • In August 2022,Lupin launched an oral drug named sildenafil for erectile dysfunction in the United States.
  • In May 2022, Aspargo Laboratories, Inc. purchased the prescription brand Bandol from the Spanish specialty pharmaceutical company Laboratorios Rubio S.A. Bandol is used to treat patients with ED problems.
  • In March 2022, the US FDA permitted Lupin to commercialize a generic version of Revatio from Viatris Specialty LLC. Lupin's ANDA for sildenafil (10 mg/mL oral suspension) gained this approval.
  • In February 2022, Tadalafil MAXON was first approved for marketing authorization by a Polish business, Adamed, under the OTC (over-the-counter) category.
  • In January 2022, for its STENDRA erectile dysfunction (ED) medication, Petros Pharmaceuticals Inc., a provider of pharmaceuticals for men's health, started two self-selection trials (avanafil).

Erectile Dysfunction Key Market Trends

  • The medication sildenafil is used to treat erectile dysfunction. By boosting blood flow to the penis, it aids males in obtaining an erection. At least two-thirds of the men who took it said their erections got better. The drug sildenafil is used to treat pulmonary arterial hypertension and erectile dysfunction, among other conditions. It is marketed under the trade name Viagra among others. Its efficacy in treating female sexual dysfunction has not been shown. The most popular medication used as initial therapy for erectile dysfunction is sildenafil (Viagra). So, throughout the projection period, the segment is anticipated to grow due to the success of Viagra (sildenafil citrate) in the treatment of erectile dysfunction.

Erectile Dysfunction Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the category that sold viagra in 2021 had the highest revenue share, at 57.8 %. North America is anticipated to rule the erectile dysfunction market. Asia Pacific is predicted to have the highest CAGR.

Report Metric Details
Market size value in 2022 USD 2.3 billion
Market size value in 2031 USD 4.73 billion
Growth Rate 8.5%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Viagra, Cialis, Zydena, Levitra, Stendra, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • VIVUS, Inc.
  • Dong-A ST Co. Ltd.
  • Meda Pharmaceuticals Inc.
  • S.K. Chemicals Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Endo International plc
  • Futura Medical plc
  • Apricus Biosciences, Inc.
  • Medtronic plc
  • Coloplast Corp.
  • Boston Scientific Corporation
  • Zephyr Surgical Implants
  • Urologix, LLC
  • American Medical Systems, Inc.
  • Augusta Medical Systems, LLC
  • Pos-T-Vac Medical
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Erectile Dysfunction Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Erectile Dysfunction Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Erectile Dysfunction Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Erectile Dysfunction Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Erectile Dysfunction Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Erectile Dysfunction Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Erectile Dysfunction Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.49 billion in 2023 to USD 4.73 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

Key market participants in the erectile dysfunction (ED) drugs market are strengthening their market positions by implementing a variety of strategies, including mergers and acquisitions and research partnerships with other businesses, to introduce novel products and solidify their market positions globally. For instance, due to a production error, Sun Pharmaceutical Industries Ltd. announced the recall of their generic medicine Tadalafil in November 2021. A small gap in the availability of generic ED medications used to treat erectile dysfunction patients may result from this recall. 'Pfizer Inc.', 'Eli Lilly and Company', 'Bayer AG', 'VIVUS, Inc.', 'Dong-A ST Co. Ltd.', 'Meda Pharmaceuticals Inc.', 'S.K. Chemicals Co. Ltd.', 'Teva Pharmaceutical Industries Ltd.', 'Endo International plc', 'Futura Medical plc', 'Apricus Biosciences, Inc.', 'Medtronic plc', 'Coloplast Corp.', 'Boston Scientific Corporation', 'Zephyr Surgical Implants', 'Urologix, LLC', 'American Medical Systems, Inc.', 'Augusta Medical Systems, LLC', 'Pos-T-Vac Medical'

Diabetes, obesity, and cardiovascular disease are on the rise due to the rise in the adoption of an unhealthy lifestyle, which in turn causes issues like ED as people age. Young people's current lifestyles are particularly stressful in many emerging nations, which has led to an increase in fast food and ready-to-eat food consumption as well as drinking and smoking. These variables are compromising general health and fitness, which in turn raises the risk of ED. Additionally, the number of ED patients increases along with the senior population growth, which continues to be a major driver of the worldwide erectile dysfunction medications market during the projection period.

The medication sildenafil is used to treat erectile dysfunction. By boosting blood flow to the penis, it aids males in obtaining an erection. At least two-thirds of the men who took it said their erections got better. The drug sildenafil is used to treat pulmonary arterial hypertension and erectile dysfunction, among other conditions. It is marketed under the trade name Viagra among others. Its efficacy in treating female sexual dysfunction has not been shown. The most popular medication used as initial therapy for erectile dysfunction is sildenafil (Viagra). So, throughout the projection period, the segment is anticipated to grow due to the success of Viagra (sildenafil citrate) in the treatment of erectile dysfunction.

The erectile dysfunction industry is expected to be dominated by North America. The prevalence of erectile dysfunction, the well-developed healthcare system, and the accessibility of treatment tools are all factors in the supremacy.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Erectile Dysfunction Market

Report ID: SQSG35I2033

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE